Mark Froimson Pacira Bio Sciences, Inc. (PCRX) insider trading activity

Mark Froimson is Director of Pacira BioSciences, Inc.. Currently has a direct ownership of 20,636 shares of PCRX, which is worth approximately $478,136. The most recent transaction as insider was on Jun 11, 2025, when has been sold 6,163 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.6K

42.58% 3M change

57.85% 12M change

Total Value Held $478,136

Mark Froimson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 11 2025	BUY Grant, award, or other acquisition	-	6,163 Added 23.0%	20,636 Common Stock
Aug 12 2024	BUY Open market or private purchase	$16,212 $11.58 p/Share	1,400 Added 8.82%	14,473 Common Stock
Jun 12 2024	BUY Grant, award, or other acquisition	-	5,230 Added 28.57%	13,073 Common Stock
Jun 14 2023	BUY Grant, award, or other acquisition	-	1,775 Added 18.45%	7,843 Common Stock
Jun 08 2022	BUY Grant, award, or other acquisition	-	1,160 Added 16.05%	6,068 Common Stock
May 09 2022	SELL Open market or private sale	$59,370 $59.37 p/Share	1,000 Reduced 16.93%	4,908 Common Stock
Dec 17 2021	SELL Bona fide gift	-	400 Reduced 6.34%	5,908 Common Stock
Jun 09 2021	BUY Grant, award, or other acquisition	-	1,066 Added 14.46%	6,308 Common Stock
Mar 15 2021	SELL Open market or private sale	$53,039 $72.26 p/Share	734 Reduced 12.28%	5,242 Common Stock

Mark Froimson

Director

Tampa, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCRX shares.

Notify only if

Value

Insider Trading

Get notified when an Pacira Bio Sciences, Inc. insider buys or sells PCRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Pacira BioSciences, Inc.

Track Activities on PCRX

Account